Key points are not available for this paper at this time.
Ketamine has been in clinical use for over half a century, yet its precise mechanisms of action remain mysterious for the large part. Its hypnotic effects appear to be largely mediated by blockade of NMDA and HCN1 receptors, but cholinergic, aminergic, and opioid systems appear to play both a positive and negative modulatory role in both sedation and analgesia. Ketamine's effects in chronic pain, and as an antidepressant, far outlast the actual drug levels, and are probably mediated by a secondary increase in structural synaptic connectivity that is mediated by a neuronal response to the ketamine-induced hyper-glutamatergic state.
Building similarity graph...
Analyzing shared references across papers
Loading...
Jamie Sleigh
University of Auckland
Martyn Harvey
Logan J. Voss
Center for Strategic and International Studies
Trends in Anaesthesia and Critical Care
University of Auckland
Waikato Hospital
Cancer Society of New Zealand
Building similarity graph...
Analyzing shared references across papers
Loading...
Sleigh et al. (Sat,) studied this question.
synapsesocial.com/papers/69e00280f3745b3748255800 — DOI: https://doi.org/10.1016/j.tacc.2014.03.002